Obesity Increases Risk for Secondary Primary Cancers in Men

This article originally appeared here.
Obesity Ups Risk for Secondary Primary Cancers in Men
Obesity Ups Risk for Secondary Primary Cancers in Men

(HealthDay News) -- Obesity before a cancer diagnosis is associated with an increased risk for overall and individual secondary primary cancers (SPCs) in males, according to a study published online Oct. 10 in the Journal of Clinical Oncology.

Sang Min Park, M.D., Ph.D., from the Seoul National University College of Medicine in South Korea, and colleagues assessed the effects of obesity before the diagnosis of a first cancer on the development of secondary primary cancers in 239,615 Korean male cancer survivors (January 2003 through December 2010).

The researchers found that over 1,614,583 person-years of follow-up, 4,799 patients had SPCs. Among cancer survivors, the age-standardized incidence rate of cancer was 1.1 times higher than that of the general population. Prediagnosis body mass index (BMI) and risk of all-combined, colorectal, liver, lymphoma, biliary tract, kidney, and obesity-related SPCs had positive linear trends. The adjusted hazard ratios for SPCs among severely obese (BMI ≥ 30 kg/m²) cancer survivors were significantly higher than those for first cancers among all cohort participants (1.41 versus 1.12).

"Prediagnosis obesity is a risk factor for overall and individual SPCs, and the strength of the BMI-cancer association is slightly stronger in male cancer survivors than in the general population," the authors write.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs